← Back to patent-cliff list
CAS 143557-99-7
3,3'-(Ethane-1,2-diylbis[[(carboxymethyl)azanediyl]methylene(4-hydroxy-3,1-phenylene)])dipropanoic acid
Codes: (IX) 828549-1-b
Application context (from source-drug indications)
Prostate cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Diagnostic agentTLX-591 companion diagnostic (Telix Pharmaceuticals)Castration-resistant prostate cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Hepatocellular carcinomaTLX-591 companion diagnostic (Telix Pharmaceuticals)Castration-sensitive prostate cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Bladder cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| TLX-591 companion diagnostic (Telix Pharmaceuticals) | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-(3-[[(Carboxymethyl)[2-[(carboxymethyl)([2-hydroxy-5-[3-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]phenyl]methyl)amino]ethyl]amino]methyl]-4-hydroxyphenyl)propanoic acid→3-(4-Hydroxyphenyl)propionic acid→2,2'-(Ethane-1,2-diyldiazanediyl)diacetic acid→3,3'-(Ethane-1,2-diylbis[[(carboxymethyl)azanediyl]methylene(4-hydroxy-3,1-phenylene)])dipropanoic acid→2,2'-[Ethane-1,2-diylbis([[5-(2-carboxyethyl)-2-oxidophenyl]methyl]azanediyl)]diacetate iron(3+)→[[2-[[[5-(2-Carboxyethyl)-2-oxidophenyl]methyl](carboxylatomethyl)amino]ethyl]([2-oxido-5-[3-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]phenyl]methyl)amino]acetate iron(3+)
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.